Association between Serum Erythrocyte Immune Function Indexes and Blue Light Treatment or the Severity of PJON

Clinical Laboratory
|October 17, 2022
PubMed

Insights

Erythrocyte immune function indexes can help diagnose pathological jaundice in children and assess blue light therapy effectiveness. These markers correlate with disease severity, aiding in treatment decisions for infant jaundice.

Area of Science:

  • Pediatric Gastroenterology
  • Neonatology
  • Immunology

Background:

  • Pathological jaundice in children presents diagnostic and therapeutic challenges.
  • Understanding the role of erythrocyte immune function in jaundice is crucial.

Purpose of the Study:

  • To investigate the association between serum erythrocyte immune function indexes and the effectiveness of blue light treatment in children with pathological jaundice.
  • To determine the correlation between these indexes and disease severity.

Main Methods:

  • 107 children with pathological jaundice and 69 with physiological jaundice were analyzed.
  • Erythrocyte immune function indexes, including red blood cell immune complex rosettes (RBC-ICR) and red blood cell C3b receptor rosette (RBC-C3bR), were measured.
  • Associations with blue light treatment efficacy and disease progression were assessed.

Main Results:

  • AUC values for RBC-ICR and RBC-C3bR exceeded 0.8 in diagnosing pathological jaundice and assessing blue light therapy efficacy.
  • RBC-ICR levels positively correlated with jaundice severity.
  • RBC-C3bR and red blood cell immune affinity receptor (FEER) levels negatively correlated with jaundice severity (p < 0.05).

Conclusions:

  • Erythrocyte immune function indexes are relevant to disease severity in pediatric pathological jaundice.
  • These indexes hold diagnostic value for pathological jaundice and can assess blue light therapy efficacy in children.
Abstract